Global Health Governance
1. Auflage April 2012
2012. 240 Seiten, Hardcover
ISBN 978-0-7456-5308-2 - John Wiley & Sons
Preis inkl. Mehrwertsteuer zzgl. Versandkosten.
Auch verfügbar als Softcover.
E-Books sind auch über alle bekannten E-Book Shops erhältlich.
In recent years the spread of diseases such as AIDS, SARS and avian flu has pushed health issues towards the top of the international agenda. Such outbreaks have serious political, economic, and social consequences and remind the world of the necessity of global cooperation in order to deal effectively with the challenges they pose.
Global Health Governance offers a comprehensive introduction to the changing international legal environment, the governmental and non-governmental actors involved with health issues, and the current regime's ability to adapt to new crises. Part 1 focuses on the evolution of international regulations aimed at stopping the spread of health problems across borders. Over the last 150 years, the nature of such cooperation, the motivations of the parties involved, and the diseases covered, has changed radically. Part 2 examines some of the most prominent actors in global health governance today, ranging from traditional intergovernmental organizations, such as the WHO and the World Bank, to private philanthropic organizations that exist outside regular global governance structures. Part 3 concentrates on some of the most pressing issues facing global health governance today, including access to pharmaceuticals, the costs and benefits of making health a security issue, and the role of civil society organizations.
Global Health Governance provides an accessible and insightful analysis of an evolving realm of global governance and cooperation. It will appeal to students of global health politics, global governance, international organization, and human security.
Aus dem Inhalt
List of Acronyms
List of Figures and Tables Acknowledgements
Part I: History
1: Early International Heath Governance Efforts
Part II: Actors
2: The World Health Organization
3: The World Bank
4: UNAIDS and the Global Fund
5: Private Actors
6: Civil Society Organizations
Part III: Key Issues
7: The Global Infectious Disease Surveillance Regime
8: Framing Health Security
9: Access to Pharmaceuticals